<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20240425061571N2</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2025-03-13</date_registration>
      <primary_sponsor>Babol University of Medical Sciences</primary_sponsor>
      <public_title>Comparison of 2 surgical methods of ostotomy with and without medial meniscus repair in patients with knee deformity accompanied by medial meniscus injury.</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of 2 surgical methods of proximal tibial ostotomy (HTO) with and without medial meniscus repair in patients with varus knee deformity accompanied by medial meniscus injury and its effect on clinical outcomes of patients: A randomized clinical trial study</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2025-04-21</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>110</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/82272</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Randomization will be performed using the permutation block method. In this method, the size of each block will be 4 and the allocation ratio in each block will be 1.1. In this way, each block will have an equal number (2 of each method) of each surgery. The order of surgery will be randomly selected by the methodologist using the sealed envelope.com software. In order to conceal the treatment process, envelopes of the same shape and size will be divided into the number of participants in the study, and the type of surgery will be written inside the envelope. Random codes will be written on the envelopes by the methodologist. When each participant enters the study, the relevant code will be recorded in the patient file. In case of severe complications, the relevant codes will be opened.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Osteoarthritis knee.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Osteotomy technique A 6 to 8 cm longitudinal skin incision was made in the anteromedial and proximal tibia from the infrapatella to the distal. After dissection of the subcutaneous tissue, the MCL was separated from the bone and retracted posteriorly. Since the ostotomy point was 4 cm from the joint surface, there was no need to cut the pes anserinus tendons and only if necessary, a 5 mm incision was made and retracted posteriorly. The patellar tendon was identified and protected with a retractor. A 2.4 mm Kirschner wire was inserted under fluoroscopy (C-ARM Fluoroscopy) from the ostotomy entry point on the medial side of the tibia in the anterior third of the tibia, which is 4 cm distal to the joint line, towards the fibular head. The tip of the Kirschner wire was placed 1.5 cm distal to the joint line and 1 cm medial to the lateral cortex. Another Kirschner wire is placed parallel to the previous Kirschner wire in the posterior third of the tibia. After placing 2 Kirschner wires, an osteotomy is performed with a saw, and special attention should be paid to attaching the blade to the wire, and we cut up to 1 cm medial to the lateral cortex, and the next cut is made under the tibial tuberosity at an angle of 110 degrees in a position where the hand is parallel to the ground. After completing the two cuts, we use the LAMINA SPREADER to open the ostotomy site. We open the LAMINA SPREADER opening according to the desired correction angle. Then it is fixed with a 6-hole locking plate. It should be noted that during fixation, there must be a sandbag under the patient's heel and the tip of the LAMINA SPREADER is placed in the posterior third of the tibia. Intervention 2: Intervention group: In addition to the ostotomy surgery below, the patient underwent arthroscopic partial meniscotomy. Osteotomy technique A 6 to 8 cm longitudinal skin incision was made in the anteromedial and proximal tibia from the infrapatella to the distal. After dissection of the subcutaneous tissue, the MCL was separated from the bone and retracted posteriorly. Since the ostotomy starting point was 4 cm from the joint surface, there was no need to cut the pes anserinus tendons and only if necessary, a 5 mm incision was made and retracted posteriorly. The patellar tendon was identified and protected with a retractor. A 2.4 mm Kirschner wire was inserted under fluoroscopy (C-ARM Fluoroscopy) from the ostotomy entry point on the medial side of the tibia in the anterior third of the tibia, which is 4 cm distal to the joint line, towards the fibular head. The tip of the Kirschner wire is placed 1.5 cm distal to the joint line and 1 cm medial to the lateral cortex. Another Kirschner wire is placed parallel to the previous Kirschner wire in the posterior third of the tibia. After placing 2 Kirschner wires, an osteotomy is performed with a saw, and special attention should be paid to attaching the blade to the wire, and we cut up to 1 cm medial to the lateral cortex, and the next cut is made under the tibial tuberosity at an angle of 110 degrees in a position where the hand is parallel to the ground. After completing the two cuts, we use the LAMINA SPREADER to open the ostotomy site. We open the LAMINA SPREADER opening according to the desired correction angle. Then it is fixed with a 6-hole locking plate. It should be noted that during fixation, there must be a sandbag under the patient's heel and the tip of the LAMINA SPREADER is placed in the posterior third of the tibia.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Allowed

When:
3 years after publication of the article

To whom:
Responsible

Conditions:
Allowed

Where to obtain:
3 years

How to obtain:
Email

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Yasin Sharifzadeh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Sardar Soleimani</address>
        <city>Babol</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>4716699118</zip>
        <telephone>+98 11 3225 2071</telephone>
        <email>dryasinsharifzadeh@gmail.com</email>
        <affiliation>Babol University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Yasin Sharifzadeh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Sheikh Tabarsi St., 14 Sardaran Alley, 2 Nima Alley, Mr. Zamanian's personal house, 3rd floor</address>
        <city>Babol</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>5157541235</zip>
        <telephone>+98 11 3225 2071</telephone>
        <email>dryasinsharifzadeh@gmail.com</email>
        <affiliation>Babol University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Age under 60 years
 and Lawrence  (4)
Knee pain and disability due to osteoarthritis that significantly interferes with employment or active recreation
Failure to respond to non-invasive treatments such as physical therapy and medication for 3 months
Medial meniscus tear based on MRI</inclusion_criteria>
      <agemin>no limit</agemin>
      <agemax>60 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Narrowing of the lateral compartment cartilage space
Lateral tibial subluxation of more than 1 cm
Loss of bone in the inner side of the tibia of more than 2 or 3 mm
Flexion contracture greater than 15 degrees
Knee bending less than 90 degrees
More than 20 degrees of correction required
Inflammatory arthritis
Significant peripheral vascular disease
Pregnancy
Opioid addiction
Diabetes</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>M19.93</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Secondary osteoarthritis, unspecified site</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Surgery</i_code>
      <i_code>Treatment - Surgery</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Osteotomy technique A 6 to 8 cm longitudinal skin incision was made in the anteromedial and proximal tibia from the infrapatella to the distal. After dissection of the subcutaneous tissue, the MCL was separated from the bone and retracted posteriorly. Since the ostotomy point was 4 cm from the joint surface, there was no need to cut the pes anserinus tendons and only if necessary, a 5 mm incision was made and retracted posteriorly. The patellar tendon was identified and protected with a retractor. A 2.4 mm Kirschner wire was inserted under fluoroscopy (C-ARM Fluoroscopy) from the ostotomy entry point on the medial side of the tibia in the anterior third of the tibia, which is 4 cm distal to the joint line, towards the fibular head. The tip of the Kirschner wire was placed 1.5 cm distal to the joint line and 1 cm medial to the lateral cortex. Another Kirschner wire is placed parallel to the previous Kirschner wire in the posterior third of the tibia. After placing 2 Kirschner wires, an osteotomy is performed with a saw, and special attention should be paid to attaching the blade to the wire, and we cut up to 1 cm medial to the lateral cortex, and the next cut is made under the tibial tuberosity at an angle of 110 degrees in a position where the hand is parallel to the ground. After completing the two cuts, we use the LAMINA SPREADER to open the ostotomy site. We open the LAMINA SPREADER opening according to the desired correction angle. Then it is fixed with a 6-hole locking plate. It should be noted that during fixation, there must be a sandbag under the patient's heel and the tip of the LAMINA SPREADER is placed in the posterior third of the tibia.</i_keyword>
      <i_keyword>Intervention group: In addition to the ostotomy surgery below, the patient underwent arthroscopic partial meniscotomy. Osteotomy technique A 6 to 8 cm longitudinal skin incision was made in the anteromedial and proximal tibia from the infrapatella to the distal. After dissection of the subcutaneous tissue, the MCL was separated from the bone and retracted posteriorly. Since the ostotomy starting point was 4 cm from the joint surface, there was no need to cut the pes anserinus tendons and only if necessary, a 5 mm incision was made and retracted posteriorly. The patellar tendon was identified and protected with a retractor. A 2.4 mm Kirschner wire was inserted under fluoroscopy (C-ARM Fluoroscopy) from the ostotomy entry point on the medial side of the tibia in the anterior third of the tibia, which is 4 cm distal to the joint line, towards the fibular head. The tip of the Kirschner wire is placed 1.5 cm distal to the joint line and 1 cm medial to the lateral cortex. Another Kirschner wire is placed parallel to the previous Kirschner wire in the posterior third of the tibia. After placing 2 Kirschner wires, an osteotomy is performed with a saw, and special attention should be paid to attaching the blade to the wire, and we cut up to 1 cm medial to the lateral cortex, and the next cut is made under the tibial tuberosity at an angle of 110 degrees in a position where the hand is parallel to the ground. After completing the two cuts, we use the LAMINA SPREADER to open the ostotomy site. We open the LAMINA SPREADER opening according to the desired correction angle. Then it is fixed with a 6-hole locking plate. It should be noted that during fixation, there must be a sandbag under the patient's heel and the tip of the LAMINA SPREADER is placed in the posterior third of the tibia.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Knee Injury and Osteoarthritis Outcome Score (KOOS). Timepoint: Four initial assessments will be conducted (at the beginning of the study, after surgery, after 1 and 6 months of surgery). Method of measurement: Knee Injury and Osteoarthritis Outcome Score (KOOS) Questionnaire.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Visual Analog Scale - VAS. Timepoint: Before intervention, 6 months after intervention. Method of measurement: Visual Analogue Pain Scale.</sec_outcome>
      <sec_outcome>Joint line convergence angle (JLCA). Timepoint: Before intervention, 6 months after intervention. Method of measurement: by marco pacs software.</sec_outcome>
      <sec_outcome>Posterior tibial slope angle. Timepoint: Before intervention, 6 months after intervention. Method of measurement: by marco pacs software.</sec_outcome>
      <sec_outcome>Hip-knee-ankle (HKA) angle. Timepoint: Before intervention, 6 months after intervention. Method of measurement: three joint view x ray.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Babol University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2025-03-10</approval_date>
        <contact_name>Ethics Committee of Babol University of Medical Sciences</contact_name>
        <contact_address>Sardar Soleimani St Babol Mazandaran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
